Trijardy Xr 00597-0390-13
Generic: Empagliflozin, Linagliptin, Metformin Hydrochloride
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 23, 2020
- Listing Expires
- December 31, 2027
- Application
- NDA212614
Need to source Trijardy Xr? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Empagliflozin | 25 mg/1 |
| Linagliptin | 5 mg/1 |
| Metformin Hydrochloride | 1000 mg/1 |
Drug Class
Dipeptidyl Peptidase 4 Inhibitor [EPC]Sodium-Glucose Cotransporter 2 Inhibitor [EPC]Biguanide [EPC]
Selected Package
00597-0390-13Selected90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-13)
Other packages for this product(1)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-71)
External Resources